09:42 AM EDT, 08/08/2024 (MT Newswires) -- Avadel Pharmaceuticals ( AVDL ) gained nearly 1% in early Thursday trading after the drug maker reported a Q2 net loss of $0.14 per diluted share, compared with a loss of $0.83 a year earlier.

Analysts polled by Capital IQ expected a $0.13 loss.

Net product revenue for the quarter ended June 30 was $41.5 million, compared with $1.5 million a year earlier.

Analysts expected $37.6 million.

Price: 16.47, Change: +0.37, Percent Change: +2.30